Syndax Pharmaceuticals Inc (SNDX)
EBITDA Growth
42.63%
Quarterly · Period ending:
SNDX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported42.63%period ending
Latest reported42.63%period ending
SNDX Quarterly EBITDA YoY % (-285118.25% → 42.63%)
Year-over-year change
High-resolution chart · PNG
SNDX ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 42.6252% | |
| 66.7795% | |
| 82.8687% | |
| 37.6595% | |
| 6.0001% | |
| -28.2561% | |
| -23.4176% | |
| -64.6682% | |
| -52.5787% | |
| -76.0874% | |
| -84.9571% | |
| -51.7906% | |
| -20.9163% | |
| -12.5346% | |
| -140.691% | |
| -68.3865% | |
| -65.5634% | |
| -34.7918% | |
| 584.431% | |
| -1.0263% | |
| -35.7578% | |
| -83.4462% | |
| -44.3419% | |
| -54.7774% | |
| -9.9625% | |
| -4.5461% | |
| 27.4812% | |
| 27.7859% | |
| 20.979% | |
| 28.2747% | |
| 3.7978% | |
| -15.7206% | |
| -37.0906% | |
| -49.4875% | |
| -78.2538% | |
| -0.3544% | |
| -59.5481% | |
| -51.3908% | |
| -65.159% | |
| -168.8426% | |
| -71.7413% | |
| -100.5533% | |
| -103.9269% | |
| 26.6943% | |
| 20.5031% | |
| -9.0224% | |
| -14.2609% | |
| -238.6772% | |
| -201.7184% | |
| -204.9042% | |
| -285,118.254% |